These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18763219)

  • 1. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
    Roepke S; Merkl A; Dams A; Ziegenhorn A; Anghelescu IG; Heuser I; Lammers CH
    Pharmacopsychiatry; 2008 Sep; 41(5):176-81. PubMed ID: 18763219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.
    Bellino S; Paradiso E; Bogetto F
    J Clin Psychiatry; 2006 Jul; 67(7):1042-6. PubMed ID: 16889446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.
    Katzman MA; Vermani M; Jacobs L; Marcus M; Kong B; Lessard S; Galarraga W; Struzik L; Gendron A
    J Anxiety Disord; 2008 Dec; 22(8):1480-6. PubMed ID: 18455360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates.
    Dannlowski U; Baune BT; Böckermann I; Domschke K; Evers S; Arolt V; Hetzel G; Rothermundt M
    Hum Psychopharmacol; 2008 Oct; 23(7):587-93. PubMed ID: 18663773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine in combination with citalopram in patients with unipolar psychotic depression.
    Konstantinidis A; Hrubos W; Nirnberger G; Windhager E; Lehofer M; Aschauer H; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):242-7. PubMed ID: 16962224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
    Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
    J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.
    Villeneuve E; Lemelin S
    J Clin Psychiatry; 2005 Oct; 66(10):1298-303. PubMed ID: 16259544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural aspects of impulsivity in alcoholics with and without a cluster-B personality disorder.
    Dom G; De Wilde B; Hulstijn W; van den Brink W; Sabbe B
    Alcohol Alcohol; 2006; 41(4):412-20. PubMed ID: 16782972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression.
    Todder D; Caliskan S; Baune BT
    J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine in patients with borderline personality disorder: an open-label trial.
    Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
    Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study.
    Vaishnavi S; Alamy S; Zhang W; Connor KM; Davidson JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1464-9. PubMed ID: 17698275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open-label study of quetiapine in anorexia nervosa.
    Bosanac P; Kurlender S; Norman T; Hallam K; Wesnes K; Manktelow T; Burrows G
    Hum Psychopharmacol; 2007 Jun; 22(4):223-30. PubMed ID: 17487935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yi-gan san for the treatment of borderline personality disorder: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashia M; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):150-4. PubMed ID: 17765378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.